CHP
AZN icon

Cable Hill Partners’s AstraZeneca AZN Stock Holding History

Cable Hill Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,554
Closed -$204K – 221
2024
Q4 		$204K Sell
1,554
-152
-9% -$21.3K 0.02% 216
2024
Q3 		$266K Sell
1,706
-35
-2% -$5.65K 0.03% 180
2024
Q2 		$272K Buy
+1,741
New +$262K 0.03% 156
2023
Q4 		– Sell
-1,528
Closed -$207K – 110
2023
Q3 		$207K Buy
+1,528
New +$209K 0.03% 184
2023
Q2 		– Sell
-1,490
Closed -$207K – 185
2023
Q1 		$207K Sell
1,490
-460
-24% -$61.9K 0.03% 192
2022
Q4 		$264K Buy
+1,950
New +$245K 0.05% 151
2019
Q2 		– Sell
-2,810
Closed -$228K – 158
2019
Q1 		$228K Hold
2,810
– – 0.08% 101
2018
Q4 		$214K Sell
2,810
-18
-0.6% -$1.41K 0.09% 96
2018
Q3 		$224K Sell
2,828
-22
-0.8% -$1.66K 0.09% 62
2018
Q2 		$200K Hold
2,850
– – 0.08% 72
2018
Q1 		$201K Sell
2,850
-35
-1% -$2.42K 0.09% 72
2017
Q4 		$205K Sell
2,885
-485
-14% -$32.7K 0.09% 83
2017
Q3 		$228K Buy
3,370
+3,222
+2,177% +$204K 0.1% 77
2017
Q2 		$10K Hold
148
– – 0.01% 402
2017
Q1 		$9K Hold
148
– – ﹤0.01% 408
2016
Q4 		$8K Buy
148
+36
+32% +$2.04K ﹤0.01% 443
2016
Q3 		$7K Hold
112
– – 0.01% 487
2016
Q2 		$7K Buy
+112
New +$6.5K 0.01% 433
2015
Q4 		– Sell
-827
Closed -$53K – 670
2015
Q3 		$53K Buy
827
+753
+1,018% +$49.5K 0.04% 124
2015
Q2 		$6K Hold
74
– – ﹤0.01% 542
2015
Q1 		$5K Sell
74
-20
-21% -$1.39K ﹤0.01% 557
2014
Q4 		$6K Buy
+94
New +$6.73K 0.01% 509

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Cable Hill Partners's AZN Position: Q1 2025 in Review

Cable Hill Partners sold out of AstraZeneca (AZN) in Q1 2025, closing a stake of 1,554 shares — an estimated $204K sold.

Cable Hill Partners first reported a position in AZN in Q4 2014 and held it in 22 quarters. The position peaked at $272K in Q2 2024. 1,250 funds tracked by Wall St. Rank hold AZN as of Q1 2025.

  • Cable Hill Partners reported no remaining AstraZeneca position as of Q1 2025 after selling out during the quarter.
  • Cable Hill Partners sold 1,554 AstraZeneca shares in Q1 2025, an estimated $204K.
  • Cable Hill Partners first reported a position in AstraZeneca in Q4 2014 and held it in 22 quarters.
  • Cable Hill Partners's AstraZeneca position peaked at $272K in Q2 2024.
  • 1,250 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2025.

Based on Cable Hill Partners's 13F filing for Q1 2025, filed 2 May 2025.